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1. RE VI EW 
1.1 Introduction 
The Dalmatian coach hound, when compared to other dog breeds, 
exhibits three characteristic abnormalities of uric acid 
b 1 . l h . . 4 9 50 93 94 h . me ta o i s m , n a me y y p e r u r i ca e mi a , y p e r u r i co s -
. 6 26 36 56 95 d . d 1 · · d uric an increase reno uric aci 
1 9 34 50 72 90 95 c earance • These properties are associated 
. h h 11 . . 26 33 94 d h 11 . . 26 33 56 94 wit ypoa antoinaemia an ypoa antoinuria 
A res~lt of these abnormalities is a high incidence of urate 
1 . h · . . h. b d5 22 88 0th d. h uro it iasis in t is ree • er iseases sue as 
recurrent dermatitis, chronic cystitis and deafness are also 
found in the Dalmatian and whether there is an~ causal re-
l t . h' ·th th · aci·d d' d · k 24 44 45 52. In a ions ip wi e uric isor er is un nown 
terms of the quantity of uric acid excreted, the Dalmatian 
dog resembles man more closely than the non-Dalmatian. On 
the other hand, in its high renal urate clearance, this breed 
of dogs differs from man, whose renal clearance values are 
lower and therefore closer to those of the non-Dalmatian. 
In this respect the Dalmatian resembles man affected with the 
inborn renal urate transport defect of renal hypouricaemia 22 . 
The significance of uric acid metabolism in t he Dalmatian has 
attracted many investigators in search of the underlying meta-
bolic defect(s). Study of the Dalmatian may also be rele-
vant to the understanding of disorders of purine metabolism 
in man for exam~le hyperuricosuria , uric acid urolithiasis 
and hereditary renal hypouricaemia. 
degradation is given in Fig. 1. 
1 
An outline of purine 
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Outline of purine degradation. (- - degradation 
pathway;----- - postulated pathway in man; X - the 
uricase catalysed reaction which does not occur in 
mo s t p r i ma t e s i n c 1 u di n g ma n ) . No t e th a t a de n i n e 
is not a product of purine degradation. 
2 
1.2 The I nitial Re por t 
The greater degre e of uric acid e xcre ti on in the urine of 
the Dal ma tian when compared with other dogs was first 
de~cribed by Benedict in 1915 6 . It was a chance discovery 
which sparked off the biochemists' interest in this breed. 
Addition of hydrochloric acid to the urine of a Dalmatian 
immediately produced a precipitate which was later identified 
as uric acid crystals. Be nedict found that this sa me animal 
on a purine-free diet excreted almost as much uric acid per 
day as an average-sized man on a similar diet. 
1.3 The Mode of Inheritance 
Trimble & Keeler, in 194081 , crossed Dalmatians with Collies 
to study the inheritance of this anomaly. They found that 
.llhigh uric acid excretion" is inherited as an "almost 
completely recessive, non-sex-linked unit character, depending 
for its expression upon the presence of a single pair of 
Mendelizing genes". Keeler pointed out that the breed must 
have been almost purebred for this characteristic over a long 
time, since Dalmatians tested in all parts of the world show 
this unique defect 32 • 
1.4 The Renal and Hepatic Handling of Uric Acid 
The conversion of uric acid to allantoin (Fig. 1) occurs in 
the live~ and this conversion cea ses in hepatectomized dogs 13 14 
Therefore researchers concentrated on the liver as the site 
o f t he me ta b o 1 i c de f e c t . 87 In 1918, Wells showed that 
Dalmatians possessed urica s e in the hepatocytes and ought 
therefore to be able to convert uric acid to allantoin in the 
same way as all other dogs. Th i s w a s c on f i r me d 1 a t e r b y 
3 
Kle mperer, Tr imb le & Ha sting s 33 who fou nd in 1938, that 
ground portion s of the l i vers of diffe r ent breeds of dogs, 
including Dal ma tians, were rich in uricase. 
were confir med by Andreini et al in 1966 3 . 
These results 
In view of these findings, it became evident that the defect 
in uric acid conversion to allantoin is due not to absence of 
uricase, but in the mechanism rendering uric acid available to 
the hepatocyte enzyme. As to the nature of this liver 
abnormality, Klemperer, Trimble & Hastings 33 suggested that 
the Dalmatian liver may have a defective urate transport 
system. An entirely different suggestion to explain the 
nature of the liver defect, was brought forward in association 
with ·the finding of another abnormality in uric acid meta-
bo lism in . the Dalmatian, namely the increased renal urate 
clearance. Very early in the study of uric acid metabolism 
in the Dalmatian, evidence was obtained indicating the 
pres~n~e of an abnormality in the renal handling of uric acid. 
92 Young, Conway & Crandall noted that the daily excretion of 
creatinine and of uric acid in the Dalmatian dog was approximate-
26 ly equal. This finding was confirmed by Friedman & Byers , 
who were also the first to demonstrate in the Dalmatian a renal 
tubular abnormality in urate handling, manifest as decreased 
reabsorption of uric acid. These investigators suggested 
the renal abnormality to be the primary and only defect under-
lying both liver and renal abnormalities. They suggested 
that the decreased oxidat i on of uric acid in the liver is due 
to more uric acid being excreted and less being available at 
the hepatocytes for conversion to allantoin. Although the 
latter suggestion was not adopted by other investigators, 
4 
the presence of the renal abnormality was confirmed in ma ny 
other studies . Woolfson, Co hn & Shore 90 found that the 
renal clearance of urate in the Dalmatian dog exceeded the 
glom·erular filtration rate, indicating that its excretion 
is the result of both glomerular filtration and active 
tubular secretion. Kessler, Heirholzer & Gurd 34 found that 
whereas uric acid underwent net reabsorption in the non-
Dalmatian kidney, it underwent net secretion in the Dalmatian. 
They found that the proximal tubule was the site of both 
urate reabsorption in the non-Dalmatian and urate secretion 
in the Dalmatian dog. Further work by Zins & Weiner 95 and 
by Mudge et ai. 50 led to the realization that uric acid is 
· 49 both reabsorbed and secreted by the renal tubule and that 
the relative magnitude of reabsorption and secretion varies 
f . 12 25 67 7 2 86 rom species to species 
From the studies conducted up to this point it became evident 
that the Dalmatian may have two abnormalities of uric acid 
me ta b o l i s m . One in the liver, in not rendering uric acid 
available to the hepatocyte uricase and the other in the 
kidney, in decreased renal tubular urate reabsorption. In 
order to establish the relationship between these two organ 
defects and the relative effect of each on the high uric acid 
excretion and on the high renal urate clearance, organ trans-
plants between Dalmatians and non-Dalmatians were performed. 
21 Cohn et al. demonstrated that transplantation of a non-
Dalmati9n kidney to a Dalmatian caused an increase in 
allantoin excretion, whereas transplantation of a Dalmatian 
kidney to a non-Dalmatian caused a decrease in allantoin 
excretion. They concluded that the Dalmatian kidney diftered 
5 
f rom that of the non -Dalma tian . They a lso s ugge sted that 
the major defect in purine metabolism, that underlying the 
hyperuricaemia and hyperuricosuria, did not lie entirely 
within the kidney. Support for the latter conclusion, is 
evident from the results of the study by Appleman, Hallenbeck 
4 & Shorter , who found that a Dalmatian, following receipt 
of a non-Dalmatian kidney, continued to excrete large amounts 
of uric acid. However, since in their experiments, the effect 
of transplantation on renal urate clearance was not recorded, 
their results do not relate at all to the question of the 
presence or absence of a uric acid transport defect in the 
Dalmatian kidney. 
A second and more plausible explanation than that suggested 
by Friedman & Byers 26 for the dual existence in the Dalmatian 
of abnormalities in uric acid metabolism in both liver and 
kidney, was furnished b~ Harvey & Christensen 29 They 
demonstrated that a specific transport system for uric acid, 
38 53 present in the erythrocytes of man and non-Dalmatians, 
appeared to be absent in Dalmatians. In view of this finding, 
they suggested a generalized defect in the transport process 
of uric acid in this breed, which would explain both the 
unavailability of uric acid to liver cell uricase as well as 
the defective reabsorption of urate in the renal tubules. 
The suggestion of a defective urate transport 1.n the Dalmatian 
hepatocytes is compatible with the suggestion made as early 
- as 19:38 by Klemperer, Trimble & Hastings 33 . Moreover, studies 
94 done more recently by Yu et al. support the evidence for such 
a defect. They caused non-Dalmatian dogs to mimick Dalmatians 
· in decreased uricase activity by administration of oxonic acid -
6 
en urica se inhibitor. The fact that the oxonate-induced 
increase in the . excretion of urate was not associated with 
increased renal urate clearance, indicated that the increased 
renal urate clearance in the Dalmatian is not due to the high 
excretion of urate. 
Whereas the presence of a urate transport defect in the 
Dalmatian liver seems indeed very likely, the presence 
i n t hi s do g o f a ge n e r a l i z e d u r a t e tr a n s po r t de fe c t a s 
suggested by Harvey & Christensen 29 , or of a renal transport 
defect, is still questionable; the former because of the 
inability of Duncan & Curtiss 24 to confirm the erythrocyte 
transport defect and the latter, because of the results of the 
1 . t l t t · · t f d b Kuster et a 1. 36 37 iver ransp an a ion experimen s, per orme y 
These investigators found that when non-Dalmatian dogs received 
Dalmatian livers, the renal clearance and excretion of uric acid 
increased to values typical of Dalmatians and that when Dalmatians 
received non-Dalmatian livers, the above parameters diminished 
to those typical for non-Dalmatians. These results were taken 
to indicate that the Dalmatian liver is responsible for both the 
increased amount of excreted urate, as well as the increased 
renal urate clearance. According to the results of this study, 
the increased renal urate clearance in the Dalmatian is caused 
by an abnormal metabolite produced in the liver, which would 
imply that there is a true urate reabsorption defect in the 
Dalmatian renal tubules. The role of the Dalmatian liver in 
the pathogenesis of the hyperuricaemia and hyperuricosuria as 
reflected in the liver transplantation experiments seems con-
vincing. However, in view of the conflicting data concerning 
t-he renal defect, the suggested role of the liver in the 
7 
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patho ge nesis of the renal abnorma lity needs furth er su ppo rt. 
Fu r t he r e vi de n c e a ga i n s t a t r u e u r a t e re a b so r p ti o n de f e c t i n the 
69 Dalmatian renal tubules was provided by Roch-Ramel et al. . 
They found that although urate is both reabsorbed and 
secreted in proximal convoluted tubules of all dogs, in the 
non-Dalmatian reabsorption prevails over secretion and in 
the Dalmatian the rates of reabsorption and secretion are 
s i mi la r. Downstream from the proximal convoluted tubules, 
net secretion occurs in the Dalmatian as compared to no net 
. . . h D 1 . 68 urate movement at composite sites int e non- a motion • 
That the role of the kidney is for from clear is compounded 
by the results of Quebberman et al. 64 65 which provide 
evidence of renal synthesis of uric acid in the dog. Whether 
the increased excretion in the Dalmatian as co mpared to other 
dogs of the renally synthesized uric acid could explain the 
hyperuricosuria found in that breed needs further inve s t i gation. 
1 • 5 Stone F o r ma ti o n 
The hyperuricosuria of the Dalmatian is associated with urate 
56 57 58 59 89 . urolithiasis. Porter , e xa mined the c he mi s try 
involved in the formation of stones by Dalmatians. He found 
this to differ from man in that most, if not all, Dalma t ian 
stones include ammonium urate crystals as opposed to human 
stones which include mostly uric acid. However, we have 
recently found a case of uric acid urolithiasis Do 1 ma ti a n 16 . 
Porter found that 6s in man, high urinary pH is beneficial in 
preventing stone formation in the Dalma t ian but rather because 
it decreases the concentration of the ammonium ion than on 
t f th . d . . d 1 b. 1 · 85 .occoun o e increase uric aci so u i ity • 
8 
1.6 He re di t ary Renal Hypo uricaemio i n Man 
Severa 1 families affected with reno 1 hypouricaemia have 
been found 22 62 . However, whether in these patients there 
is a true renal transport defect for uric acid or whether 
there is in them, as suggested for the Dalmatians, an 
abnormal metabolite produced in the liver which affects renal 
urate handling, has still to be resolved. 
1. 7 Fa c tor s Re 1 a t e d to Ve t e r i n a r y Me di c i n e 
The Dalmatian breed of dogs has seYeral biological aberrations 
in addition to uric acid metabolism. Duncan & Curtiss24 
listed some which include congenital deafness, cardiac 
arrythmias, ocular abnormalities, urinary tract disease and 
recurrent dermatitis. In 1969, the Dalmatian Research 
Foundation was started by J.C. Lowrey of Pennsylvania. He 
speculated on the connection between the unique uric acid 
me~abolism and some of the above diseases, such as recurrent 
. 43 52 cystitis and dermatitis found in Dalmatians • Individual 
cases treated with allopurinol (Zyloprim, Calmic), a xanthine 
oxidase inhibitor which prevents the degradation of hypoxanthine 
and xanthine to uric acid (Fig. 1), showed improvement. However 
the role of the other concurrent treatment was not made clear. 
Lowrey, Barron & Niebert 45 in 1973 and Muller & Kirk 51 in 1976 
used the term "bronzing" to describe a specific Dalmatian 
skin condition. They linked it with hyperuricosuria, uric 
acid uroliths and urinary tract infections. Although they 
advocated allopurinol therapy, there is as yet no sound 
biochemical basis for its use in this condition. Veterinarians 
have reported satisfactory results using the uricosuric agent, 
9. 
Benz bromar one (Minuric, Rec kitt & Colman ) 47 48 in acra l lick 
dermatitis and ot her non-specific dermatitis in Dalmatians 
(G.J. Futter, 32 Blue Route Centre, Tokai, Personal communication). 
However further investigations are necessary to ·evaluate the role 
of this drug in veterinary medicine. 
1.8 Summary 
The Dalmatian coach hound differs in its uric acid metabolism 
from all other breeds of dogs, in that it is hyperuricaemic 
and hyperuricosuric and it exhibits increased renal urate 
cl~arance. The decreased oxidation of uric acid by the 
liver uricase has been suggested to result from a defective 
uric acid transport into the hepatocytes. Possible models 
to explain the increased renal urate clearance include a 
similar transport defect in the kidney, or the presence of an 




-2. MEASUREMENT OF URATE CONCENTRATIONS IN BLOOD AND URINE 
2.1 Methods 
The enzymatic method of Kalckar 31 as modif i ed by Praetorius60 61 
Praetorius and Poulson 63 and Liddle et al. 4 1 was used. 
uric acid+ 2 H20 
uricase 
Uric acid absorbs ultraviolet light maximally at 293 nm 




Borate Buffer 100 mmol/l pH 9,5 
Uricase 10 U/ml 50% glycerol 
Glycerol 50% 
All from Boehringer Mannheim Cat. no. 124737 
2.1.1.2 Instruments 
Both the Varian Techtron model 635 coupled to a Corning recorder 
model 840 and the Centrifichem (Roche, New York, U.S.A.) were 
used. 
2.1.1.3 Standards and Samples 
Standard solutions of uric acid in water at the following 
dilutions were prepared: 
0,01 0,02 0,05 0,1 0,2 0,3 0,4 mmol/l 
Blood was aseptically collected in heparinized syringes from 
80 Dalmatians and 99 non-Dalmatians. 
fhe plasma was stored at -20°C. 
ll 
After centrifugation, 
Urine samples were aseptically collected by cat he terization 
0 from 23 Dalmations and stored at -20 C. 
2.1.2 Procedure 
2.1.2.1 Calibration 
0,6 ml of the standards was pipetted into Eppendorf tubes 
and spun in a Eppendorf centrifuge (model 5412) for 4 minutes. 
0,4 ml supernatant was added to 4,4 ml buffer. After mixing 
1 ml of this, it was added to 4 test tubes as follows to 
allow duplication of the measurements. 
row A 1 3 
row B 2 4 
To row B 4 ml glycerol was added and mixed. 
ferred to cuvette A and B 2 to cuvette B. 
A 1 was trans-
4 ml uricase was 
added to cuvette A, mixed well, and the recorder started 
immediately. This was continued for the rest of the 
measurements. 
From this, the time for the reaction to proceed to completion 
at each standard dilution can be deter mined (Fig. 2). 
2.1.2.2 Standards and Samples 
Actual values for the standards and plas ma s were obtained in 
a similar manner with the uricase added to row A and mixed 
in well before being transferred to the cuvettes. Urines 
were diluted 1 : 20 and evaluated as for the sere and 
standards. 
2.1.3 Calculations 


























0 2 4 6 8 10 
Time (min) 
The .action of ur i case on standard solutions 
. (in mmol/l) of uric acid(a~0,05; b:0,2; 
c:0,3). 
13 
. 1 A h . 1 d . 61 is proportio na t o , t e o pt ica ensity When t he 
light pat h is l . cm then A= EC where E, the extinction 
coefficient at 293 nm and pH 9,5 is 12,5 x 103 
C A x 12 plasma = mmo 1/!. 
C . urine 
2.2 
2. 2. 1 
12,5 
A x 240 mmo 1/_!. 
= 12,5 
Results and Discussions 
Standards 
-1 41 cm 1-1 mo 
The time for 0,04 U uricase to completely oxidise the standard 
solutions was approximately 5 minutes (Fig. 2). Mixing the 
uricase in the test-tubes rather than the cuvettes gave end 
results closer to the standard concentrations (Table 1). 
Table 1. 








Comparison of standard concentrations and results 
obtained spectrophotometrically. 
No difference was detected between the results obtained on the 
centrifugal analyser and those obtained on the spectrophotometer. 
2.2.2 Plasma and Urinary Values (Table 2) 
As a comparison plasma values from 259 human individuals are 
included (Professor E.H. Harley, Personal communication). 
14 
. Sample Species Sample Mean Standard Skewness 
size mmol/_l deviation 
Dalmatian 80 0 I 136 0,074 0 I 97 
Plasma non-Dalmatian 99 0,074 0,033 1,05 
Man 259 0,28 0,070 -
Urine Dalmatian 23 2,66 1,56 1,33 
Table 2. Plasma and urinary uric acid levels. 
Values for a small series of urine samples are shown for 
interest but in the absence of accurate increments of volumes 
of urine per unit time these are of rather minor value and the 
large standard deviations reflect the wide scatter of the 
values obtained. 
The plasfT!a mean for the Dalmatians is approximately half 
that of man. The skewness being positive shows skewing to 
the right or towards the la:rger values. 
Student's t test for two samples showed the Dalmatian and 
non-Dalmatian plasma concentrations to be from different 
populations at a probability less than 0,0007 and the 
logarithm values to be different at probability less than 
0 ,0001. 
For positively skewed distributions, a more valid determination 
of standard deviations (which requires a reasonably close 
approximation of the data to a normal distribution) can 
sometimes be achieved by analysing the logarithms of the data 
values. The Dalmatian and non-Dalmatian plasma values were 
therefore multiplied by 100 and converted to their logarithms 
to the base 10. Statistical analysis of these are listed 
.in Tab le 3. 
.15 
. Spec ies 
Dalmatian 
















Tab le 3. Lo go r it h ms of the plasma uric acid le ve 1 s. 
Histograms were drawn for the plasma and urine samples on 
a Hewlett-Packard (model- 85) desk-top computer (Figs. 3 & 4). 
At cell widths selected to represent the data best, these 
emphasize the skewness. Although this appears to be greater 
I 
in the , Dalmatian in Fig. 3, the skewness value is lower 
(Table 2) than in the non-Dalmatian. For comparison, the 
s a me c e 11 w i d t h s we re u s e d for t he 1 o ga r i t h m h i s to gr a ms a s i n 
the histograms. As the plot demonstrates (Fig. 4), the 
approximation to a normal distribution is not improved by 
ta k i n g 1 o ga r i t h ms o f t he d a ta • In a set of data such as 
the plasma urates where the skewness value is large, the 
median (the value which divides the set into two numerically 
equal groups) represents the data more accurately. A 
measure of the spread of the data is given by the percentiles 
(values which divide the distribution into hundredths). The 
25 and 75 percentiles (lower and upper quartiles) are listed 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































. The u s e o f t he s t u de n t ' s t t e s t o n d a ta w h i c h i s n o t no r ma 11 y 
distributed is questionable. However, the Mann-Whitney test 
gives the difference between non-parametric distributions 
(Dr. L. Underhill, Department of Mathematical Statistics, 
University of Cape Town, Personal co mmunication). The 
Mann-Whitney test computed with the BMDP3S program (Health 
Sciences Computing Facility, University of California, Los 
Angeles, U.S.A.) gave a test statistic of 5995 which shows 
a difference between the Dalmatian and non-Do lmatian plasma 
uric acids at p less than 0,0001. Although the plasma uric 
acid levels are listed for convenience in Tables 2 & 5 as if 
they were normally distributed, the above factors must be 
considered. However, that the Dalmatian and non-Dalmatian 
plasma urates are from different populations (as suspected 
from the student's t test) is shown by the Mann-Whitney test. 
2.3 Conclusions 
The plasma uric acid values in the Dalmatians and non-Dalmatians 
were higher than those found by other researchers (Table 5). 
That Dalmatian plasma uric acid levels are appro ximately 
double those of non-Dalmatians is consistent with their 
findings. The value of the data as listed in Table 5 must 
be considered in the light of the sample sizes. The large 









































































































































































































































































































































































;3. PURINE UPTAKE BY CANINE CELLS 
3.1 Introduction 
Fibroblasts and white blood cells were obtained from 
Dalmatians and non-Dalmatians. These were incubated in media 
containing labelled purines. Purine uptake was compared in 
Dalmatian and non-Dalmatian cells. 
3.2 Methods 
3.2.l Media 
The medium used unless otherwise specified was Ham FlO 
(Nutrient mixture with L - Glutamine, Gibco Europe, U.K.) 
to which foetal calf serum and antibiotics had been added 
to give the final concentrations as listed. 
Foetal calf serum 15% 
Penicillin 100 U/ml 
Streptomycin 50 )-lg/ ml 
Neomycin 50 ,ug/ml 
3.2.2 Cells 
Fibroblasts were grown from Dalmatian and non-Dalmatian skin 
biopsies. 
White blood cells were _prepared from blood aseptically collected 
from Dalmatians and non-Dalmatians in heparinized syringes. 
3.2.3 Biopsy Technique 
The ventral abdominal area of dogs was cleansed by scrubbing 
with Hibiscrub (I.C.I., Johannesburg, South Africa), followed , 
by swabbing with alcohol. 
21 
The skin was held between the thumb and forefinger to raise 
a ridge. A 26 · gauge needle was inserted through the crest 
close to the surface. A scalpel blade was run through just 
beneath the needle to slice off a small (approx. 2 mm3 ) piece 
of skin which remained attached to the needle. 
3.2.4 Explantation 54 
The biopsy was transferred to a sterile petri dish with a 
drop of medium added to keep it moist. The biopsy was 
3 dissected into 1 mm pieces and transferred to a new petri 
di sh. A drop of medium was added and a sterile coverslip 
placed over the pieces. 1,5 ml medium was added and the 
petri dish placed in an incubator (Hotpack, model 351820, 
Philadelp~ia, Pennsylvania and the Farma Scientific, model 
3019, Marietta, Ohio). Incubation conditions were 37°C, 
4% CO 2 and 90% relative humidity. 
was changed twice weekly. 
The cell culture medium 
3.2.5 Subculture and Harvesting the Cells 
200 ml of stock solution of versine-trypsin contained 
Na Versinate 0,4 g 
NaCl 16 ,0 g 
KCl 0,4 g 
Na 2HP04 2,3 g 
KH 2Po 4 0,4 g 
trypsin 2,5 g 
The pH was adjusted to 7,5 and 10 ml aliquots and were stored 
0 at -20 C. 
Prior to use, 10 ml of stock solution was thawed and made up 
22 
to 100 ml with sterile water. The medium was removed from 
the cultures whjch were washed twice with 0,5 ml versine-
trypsin. This was repeated and the petris were placed in 
the incubator for 2 minutes. The cells were dispersed by 
vigorous pipetting with 1,5 ml medium. At this stage , 
the cells were distributed in a 1 : 3 split ratio amongst 
new petri dishes or 25 ml Falcon flasks in fresh medium. 
3.2.6 Transformation of Lymphoblasts 
An attempt was made to establish a permanent line of canine cells 
because of the short lifespan of lymphocytes and cultured 
fibroblasts. Since Epstein-Barr virus transforms human cells 
to a permanent lymphoblastic cell line, the same approach was 
used with canine lymphoblasts to ascertain whether these 
are also transformable. The transformation medium contained 
the Epstein-Barr virus grown in the marmoset (95,8)8 cell line. 
Marmoset cells were cultured and centrifuged (730 G for 5 min) 
when needed. After filtration, they were diluted with an 
equal volume of medium and divided into 20 ml aliquots. 7 ml 
Ficoll-Pacque (Pharmacia, Uppsala, Sweden) was added to sterile 
test-tubes. 10 ml whole blood was carefully layered on top. 
After centrifugation (730 G,15 min), the white blood cells 
formed a distinctive layer which was removed by pipetting. 
10 ml medium was added and the suspension centrifuged to wash 
the cells. The wash was discarded and the pellet resuspended 
in 4 ml transforming medium. The culture was incubated and 
e xa mined at re gu la r inter va 1 s. 
3.2.7 Preparation of White Blood Cells 
·white blood cells for labelled purine uptake studies were 
23 
collected and separated from red blood cells by the methods 
given in section 3.2.6. These were stored resuspended in 
medium for up to 24 hours. Prior to the experiment an 
aliquot was counted in a coulter counter (Coulter Electronics, 
Hialeah, Florida), centrifuged, and the pelletted cells 
resuspended in lobe 11ed medium. 
3.2.8 Labelled Purines 
These were obtained from The Radiochemical Centre, Amersham, 
En gland (Ta b le 6 ) • 
Purine Lobe 1 













57 mCi/mmo 1 








Table 6. Labelled purines used in canine cell studies 
3.2.9 Cultured Canine Fibroblasts 
The labelled purines used in these studies (Table 7) were 
dissolved in the medium to give a final concentration of 
5 ,.u Ci/ m 1 o f ea c h i n t he p i 1 o t s t u d y a n d e x p e r i me n t 1. 2 . 
In experiment 1.1, two media were prepared. Me di um A 
contained 5µCi/m1 of each labelled purine and medium 8 
contained the same labels and 1 mmol/~ unlabelled hypo-
xanthine29 53 • . Petri dishes of Dalmatian and non-Dalmatian 































































































































































































































































































































































- After re moval from the incubator, the cells were washed with 
10 rapid change? of cold medium. 0,2 ml cold 0,5 mmol/l 
perchloric acid (PCA) was added to the petri dishes for 4 
min at 5°C. After centrifugation, the PCA supernatant 
was removed and neutralised with 25µl 2 mmol/l K2co 3 , 
centrifuged again and 200.J-ll transferred to scintillation 
vials. (In experiment 1.1, 200 µl from one petri dish 
each of a Dalmatian and a non-Dalmatian was retained for 
high performance liquid chromatography). 
The PCA precipitate was dissolved in 0,5 ml 0,1 mmol/l 
NaOH, neutralized with 0,5 ml 0,1 mmol/l HCl and transferred 
to scintillation vials. 
3. 2. 10 White Blood Cells 
White blood cells were incubated in duplicate in the labelled 
me di a a s i n Ta b 1 e 8 . 
. The procedure and labelled purines differed in experiment 
2.3 from those in experiments 2.1 and 2.2. The con-
centrations of the labels in the media of experiments 2.1 
and 2.2 were 5 ),A Ci/ml for 3H uridine and 1 y.Ci/ml for 14c 
hypoxanthine. The concentrations in experiment 2.3 were 
lp.Ci/ml for 
14c uric acid and 20 J,ACi/ml for 3H hypoxanthine. 
3.2.10.1 Experiment 2.1 and 2.2 (Table 8) 
In experiments 2.1 and 2.2, the cells were resuspended in 
0,75 ml labelled med~um per test-tube and placed in the 
incubator. The test-tubes were agitatea every 0,25 hours. 
0,4 ml aliquots of a well-mixed suspension was transferred 
to Eppendorf tubes at the end of the incubation period(s). 















































































































































































































































































saline by resuspen di n g the pellet, spinni n g down a nd removing 
the supernatant~ into scint illation vials . 0,5 ml 
1 mol/l PCA was added to 0,5 ml saline-suspended cells and 
p 1 a c e d o n i c e for 5 mi n . A ft e r c e n tr i f u ga ti on a go i n , 0 , 7 m 1 
of this PCA supernatant was removed and 37 ,5 JJl 5 mol/l K2co3 
added slowly to neutralize the PCA. After centrifuga t ion, 
0,7 ml supernatant was transferred to scintillation vi als. 
The pellets were washed once with 0,5 ml cold saline and the 
wash discarded. The pellets were left in 0,5 ml 0,1 mol/l 
NaOH at 65°C for 1 hour to dissolve. This was then 
neutralized with 0,05 ml 1 mol/1 HC1 and transferred to 
scintillation vials. 
3.2.10.2 Experiment 2.3 (Table 8) 
In order to reduce the number of counts in the post i ncubation 
wash a method was derived to speed up this step in 
· experiment 2. 3. The medium and ce 11s were centrifuged (in 
a refridgerated centrifuge) through a layer of saline wash 
to reach the PCA almost immediately. Test-tubes were 
prepared with 0,5 ml cold 1 mol/1 PCA (containing 20% 
by volume of glycerol) as the bottom layer. ·3 ml cold saline 
(containing 10% glycerol) constituted the middle layer. 
0,7 ml of the medium containing the cells was carefully layered 
on top. After centrifugation, the layer containing labelled 
medium was carefully removed with a LKB (Bromma) 1200 
peristaltic pump. The pump was flushed, reversed until a 
bubble of air just appeared, and the tip was plunged to the 
bottom layer to remove the PCA supernatant. This was 
neutralized as in experiments 2.1 and 2.2 and transferred to 
scintillation vials. The remaining layer (the wash) was 
28 
decante d i nt o sc i nt illation vials. 0 , 5 ml cold 1 mol/l 
PCA was used to _ re suspend the cells and transfer them to 
Eppendor f tubes. The cells were washed twice again in cold 
1 mol/lPCA. The last wash was decanted and the PCA pre-
cipitates were left in 0,5 ml 0,1 mol/l NaOH at 65°C for 
1 hour to dissolve. After neutralization (as in experiment 
2.1 and 2.2) these were transferred to scintillation vials. 
3.2.11 Scintillation Counting 
10 ml Insta-gel scintillation fluid (United Technologies, 
Downer•s Grove, Illinois, U.S.A.) was added to the 
scintillation vials prior to counting in the ~-counter 
(Beckman LS-250, Irvine, California, U.S.A.). A computer 
printout of the quench curves and co-ordinates is 
Fig. 5. 
. . given in 
. 3. 2. 12 High Performance Liquid Chromatography (HPLC) 
Varying gradient analysis was performed on the Spectra-
Physics liquid chromatograph SP3500 B (Santa Clara, 
California, U.S.A.) with a buffer of 0,8 mol/l NH4H2Po4 
pH 4.5 as solution Band distilled water as solution A. 
The Spectra-Physics 1011 Lichrosorb anion exchange column 
(Santa Clara, California, U.S.A. and E. Merck, Darmstadt, 
West Germany) was coupled to a Spectra-Physics model 770 
Spectrophotometer set at 260 nm wavelength. The elution 
profiles were drawn on a Unicord chart recorder at a chart 
speed of 75 cm/hr. Elution times of_unlabelled uric acid 
a~d uridine nucleotide standards were recorded at a pressure 
of 3000 psi, flow rate 4 ml/min and a 3 - 99% gradient. 
Under the same conditions, 200µ1 of a labelled PCA su·pernatant 
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f r om a Dalmatian and non-Dalmatian (e xperiment 1.1) were 
injected and 15 se cond fractions collected in scint i llat i on 
vials for 10 mi n and counted (Fig. 3). 
An isocratic elution of 12% of a 0,8 mol/l NH4H2Po4 buffer 
so l u t i o n w a s u s e d for so me e x p e r i me n t s ( see Fi g . 6 ) • 
3.3 Results and Discussion 
3. 3. l Cell Culture 
After a lag phase of 2 - 3 days, the fibroblasts grew out 
rapidly from the explant. Compared with human fibroblasts, 
they had a more granular appearance. The cells were 
subcultured after an average of 14 days. Senescence began 
very much earlier than in human fibroblasts grown in the 
d · t · 54 d 1.· t t · bl t th 11 same con 1._ ions , an was no poss1. e o grow e ce s 
. beyond. the second passage. It was therefore necessary to 
. harvest the cells at an average of 10 days after the first 
subculture. 
In an attempt to promote further growth and prevent early 
senescence, Eagle's minimum essential medium (Gibco Europe, 
U.K.) with added glutamine and antibiotics (so that the 
final medium contained 2% glutamine, 100 U/ml penicillin, 
50 J.tg/ml streptomycin, 50 }-lg/ml neomycin) was used ·on 5 
explants. This was unsuccessful - the cells grew very 
s l6wly or not at a 11. 
3.3.2 Lymphoblast Transformation 
The canine blood samples yield high white blood cell counts 
with the Ficoll-Pacque method as compared to human blood. 
Attempts at lymphoblast transformation was unsuccessful 
3.0 
. 
233 . . 350. 468 585. 702. 819 . 
~--=: ( 1 ) = 634 Y< 1 ) = 18 2 
::-:; ( 2 ) 561 \ .. • ~. ) = 1 ,:, •:, = ( • .. .c. .... <... 
>=: ( 3 ) = 479 Y< ""] ) = 16 1 ..., 
X( 4 ) 385 Y( 4 ) = 12 C" = ·-' 
3-H in 3-H ch .:rnne 1 coot·dinates 
-:1 t·e = 
A= -23 . 8149148328 
B = .137185108224 
C = -1 .11669265031E-4 
X( 1 ) = 683 Y( 1 ) = 2 . 8 
XC 2) = 480 Y< 2) = 6 
XC 3 > = 292 Y( 3 J = 10 . 7 
14-C in 3-H channel coordinate 
s a t·e = 
A= 21 . 3109495599 
B = -4.32366799456E-2 
C = 2.36226424257E-5 
X( 1 ) = 683 Y( 1 ) = 66 . 4 
XC 2) = 480 YC 2) = 33 . 2 
X( 3) = 292 Y( 3) = 7.8 
14-C in 14-C channel coordinat 
es at·e = 
A= -21 . 4561570313 
8 = 7.89529293998E-2 
C = ?.27376342188E-5 
fig. 5 Printout of quench curve and co-ordinates. 
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altho ugh the method used here has a 95% success rote in 
human lymphoblasts (Dr. L.M. Steyn, U.C.T. Medical School, 
Cape Town, Personal communication). It is probable that 
canine lymphoblasts do not have the receptors to Epstein-Barr 
virus. The absence of reports of infectious mononucleosis 
or an equivalent disease in dogs supports this. 
3.3.3 Labelled Purine Uptake into Fibroblasts 
Th 1 b 11 d . d 14c . . d d 3H . d. e a e e purines use were uric aci an uri ine 
(Table 7). The counts obtained in the PCA supernatant of 
the pilot study were adequate. The 14c dpm/3H dpm ratios 
obtained in the pilot study were identical in the Dalmatian 
and non-Dalmatian in the PCA supernatant. The 14c dpm 
in the pilot study PCA precipitates dropped to background 
leve 1. Since only 1 petri dish each from a Dalmatian 
and a non-Dalmatian were used in the pilot stud~ no conclusions 
- could be drawn. 
The results of experiments 1.1 and 1.2 are listed in Table 9. 
The means of the ratios were lower in the Dalmatians than the 
non-Dalmatians. The addition of hypoxanthine to the medium 
in experiment 1.1 did not appear to make any difference to the 
uptake of uric acid by either Dalmatians or non-Dalmatians. 
The value of t he means as listed in Table 9 must be interpreted 
in the light of the sizes of the samples. Certain 1 y , i t wa s 
not possible to statistically evaluate the differences of one 
of the small- samples. In experiment 1.1, the 1 hour 
. b . . h 14c . . d d 3H . d. d . incu ation wit uric aci an uri ine oes not give a 
statistically significant difference for the Dalmatian compared 











































































































































































































































































































































































































































, resul ts of the one hour incubation periods in experiment 1.1 
(that is the 14c uric acid versus 3H uridine and the 14c uric 
acid versus 3H uridine in the presence of hypoxanthine) which 
we can do since hypoxanthine does not appear to affect the 
uptake of the labelled purines, two samples of size 8 are 
formed. h h k f 14c . . d 3H . d. Tat t e vpta e o uric aci versus ur1 1ne is 
significantly less in the Dalmatian, can be seen from Table 10. 
The statistical evaluation of the results of experiment 1.2 are 
listed in Table 11. These show that uric acid uptake in 
Dalmatian fibroblasts (as compared to non-Dalmatians) is 
deficient when compared to uridine. A 1 though the method of 
bulking the results of experiment 1.1 (1 hour incubation with 
and without hypoxanthine), is questionable, the low p · values 
obtained ~ere and in experiment 1.2 are possibly o f over-riding 
importance. The counts in the PCA supernatants of experiments 
1.1 and 1.2 were of the same order as those in the pilot study 
and were considered ad~quate. However, counts in the PCA 
precipitate were very low when compared with the PCA super-
natant and in fact the 14c counts had dropped to background 
le ve 1. 14c/3H ratios were therefore of no value. 
The results of the HPLC analysis of a labelled PCA supernatant 
from a Dalmatian are given in Fig. 6. This is almost iden-
tical to a non-Dalmatian PCA supernatant. 3H profiles showing 
the label in the positions for uridine, uridine-mono-
phosphate (UMP), uridine-di-phosphate glucose (UDPG) 
uridine-di-phosphate (UDP), and uridine-tri-phosphate (UTP) 
were obtained. The UTP : UDP ratio was almost 10 : 1. 
Since the major labelled peak of 14c did not exactly 
34 
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.012 
PROB t > 2.9971 = .0048 
Table 10. Statistical evaluation of 
experiment 1. 1 
correspond to the marker urate (run previously), its identity 
was checked by re-injecting the sample and collecting the eluate 
under the peak. 
An isocratic elution of 12% of a 0,8 mol/l NH4H2Po4 buffer 
so 1 u ti on w a s u ·s e d for t he f o 11 ow i n g two i n j e c ti on s ( Fi g • 7 ) • 
40,>A-_! of a saturated uric acid solution (to act as an un-
labelled marker) was first injected with 10)-l.._! of the eluate 
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. collected under the peak and 15 second fractions counted. 
The second inj~ction consisted of 40,_.._l saturated uric acid, 
t :3 TATISTIC FOF.: THE MEAt·~S OF Tl~O 
SAMPL ES 
I >~ ( I ) 
1 1 100 
•:, 
.:... 0790 
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10 03:30 
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·-' 0:::: 4(1 
H FOF.: 1 = 1 (1 
1 MEAN - . 067 
STD . DE~} FOF.: 1 = .020 
N FOF.: 'j = C" .:... ·-' 
2 MEAN = 1214 
STD. DE~.J. FOR 1 = . 031 
t= 4 1 77,-, I _, •=- DF= 13 
F'~:08 1: '· 4 1738 = . 01305 ,. 
Tab le 11. Statistical evaluation of 
e xpe rime n t 1. 2 
10,>l_l of the eluate collec·ted under the peak and 0,04 U uricase. 
This was mixed well, deproteinised (to remove the uricase) and 
injected with 15 second fractions counted (Fig. 7). 
In the first injectio~, the label eluted in the major peak 
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injection (Fig. 7 b) , this peak had disappeared from both the 
labelled and unlabelled traces. However it reappeared strongly 
at fraction 8 in what must be allantoin (Fig. 7b). This con-
firms the peak in question in Fig. 6 to be uric acid. The 
labelled species at fraction 22 in Fig. 7b is probably an 
intermediate in the uricase catalysed conversion of uric acid 
to allantoin7 20 27 82 
3.3.4 Labelled Purine Uptake into White Blood Cells 
The labels used in these experiments were 14c hypoxanthine 
versus 3H uridine (in experiments 2.1 and 2.2), and 14c 
uric acid versus 3H hypoxanthine (in experiment 2.3). The 
labels, lengths of incubation and results are listed in Table 
12. The method devised for experiment 2.3 was an attempt 
to reduce the counts in the post-incubation wash step. As 
shown in Table 13 the counts in the wash (relative to the 
counts in the supernatant) were reduced in the 14c label but 
increased in the 3H label by the revised method. 





counts in wash/ 
me a n co u n t s i n 
Wash Supernatant supernatant 
,3H .14c . 3H 14c . 3H . 14c 
6000 1050 131000 1600 0,05 0,66 
8800 191 58000 405 0, 15 0,47 
The counts in the wash volumes and supernatants 












































































































































































































































































































































































































































































































































The number of cells used in each experiment did not affect t he 
14c/3H dpm ratios. As an example the number of cells used in 
each test-tube of experiment 2.2 and the results obtained are 















Tab le 14. 
Ratio 14c/3H dpm 
No. of cells 
(millions) 
Supernatant Precipitate 
6,6 0,005 0,02 
6,8 0,014 0,02 
7,0 0,019 0,04 
8,5 0,019 0,05 
1, 0 0, 022 0,04 
1,2 0,031 0,06 
1,0 0,011 0,02 
1,4 0 t 007 0,02 
1,3 0, 014 0,02 
2,4 0, 014 0,03 
1,0 0, 018 0,02 
1,4 0, 022 0,04 
The numbers of cells used and the ratios obtained in experiment 2.2. 
The statistical evaluations of the PCA supernatants (Table 12) 
reveal~d no differences in the uptake of either 
14c hypoxanthine 
3H . d. 14c . . d 3 h versus uri ine or uric aci versus H ypoxanthine. From 
Table 12 the ratios in the PCA precipitate were significant 1 y 
lower in the Do lmatian than in the non-Da lma ticin in experiment 
2. 1. However this is reversed J. n experiment 2.2. It appears 
41 
. therefore that there is no difference in the uptake of 
hypoxanthine v~rsus uridine. From the results of experiment 
2.3, there appears to be no difference in the uptake of uric 
acid versus hypoxanthine. 
3.4 Conclusions 
The canine fibroblasts required for metabolic studies were 
cultured from Dalmatian and non-Dalmatian skin. The supply 
of cells was limited by the quantity obtained and early ,. 
senescence. Canine lymphoblasts do not appear to - transform 
in the presence of the Epstein-Barr virus thereby restricting 
the availability of this cell for metabolic studies. However, 
the quantity of white blood cells obtainable from canine 
blood was sufficient for experimentation. 
The uptake of purines by canine cells was studied by the 
method of double-labelling with radioactive isotopes. This 
is a useful way of avoiding the errors involved in relating 
counts to cell numbers or cell protein concentrations when 
the latter may be small. It compares the flux through one 
metabolic pathway with the flux through a reference pathway. 
HPLC with the anion exchange column is useful in identifying 
products of labelling experiments. Peak shift after uricase 
treatment enables the label in uric acid to be identified 
unequivocally. 
The labelled purine uptake studies on canine fibroblasts 
(section 3.3.3) showed a deficient uptake of uric acid (relative 
to uridine) by Dalmatian cells compared to non-Dalmatian cells. 
Uric acid uptake (relative to uridine uptake) was not affected 
by the presence of hypoxanthine -(section 3.3.3). There fore 
42 
, the r e must be a defect in the transport o f uri c a c i d acro ss 
the fibroblast cell wall which is not affected by hypoxanthine. 
That there is a defect across fibroblast cell walls agrees with 
Harvey & Christensen's findings in red blood cells 29 . However, 
the defect diffeis in fibroblasts in that it was not affected 
by hypoxanthine. 
The labelled purine studies on canine white blood cells (section 
3.3.4) showed no difference between uptake in Dalmatian cells 
from non-Dalmatian cells. The defect found both 
in fibroblasts in the present study and in red blood cells by 
Harvey & Christensen 29 , is absent in white blood cells. 
~3 
CHAPTER 4 
4. IN VIVO STUDIES ON ADMINISTERED PURINES 
4.1 Introduction 
The fate of purines in Dalmatians and non-Dalmatians was studied 
f d . t d . . t t. 14c Uri' C a ci' d a ter per os an in ravenous a minis ra ion. 
and 3H hypoxanthine were administered and urines (after per os 
administration) and urines and sera (after intravenous 
administration) were collected, counted and the compounds 
carrying the labels identified. 
Urate output and renal clearance of uric acid were calculated 
for 2 Dalmatians and 2 non-Dalmatians from specimens of urine 
and serum collected after intravenous administration of 
labelled purines. 
4.2 Methods 
4.2.l Labelled Purines Administered 
14c uric acid and 3H hypoxanthine were obtained as listed in 
Table 6 of section 3.2.8. 
The fed solutions were prepared by dissolving 50 >4Ci 14c uric 
acid and 400~Ci 3H hypoxanthine in 11 ml 5 mmol/l NaHC03 . 
8 ml of milk was added and after thorough mixing, the solution 
was divided into 4 equal amounts and administered immediately. 
The intravenous labels were stored separately until just prior 
to administration. 400 µCi 3H hypoxanthine was dissolved in 
0,5 ml sterile 5 mmol/l NaHC03 , and divided into 4 equal portions 
which were stored at -20°C. 50}.tCi 14c uric acid was similarly 
dissolved and divided into 4 portions. Just prior to 
ddministration, a 3H hypoxanthine portion and a 14c uric acid 
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.por tion were diluted in 4 ml 5% dextrose solution, thoroughly 
mixed to gether _and t ransferred to a s yr i nge. 
4.2.2 Selection of Experimental Subjects 
Young, healthy adult dogs of approximately the sa me age were 
se le cte d. Two pure-bred Dalmatian dogs (Dl and D2) were 
used in both the per os and intravenous experi ments. Two 
different pairs of non-Dalmatians (Ml - M4) were used. The 
weights, ages and sexes are listed in Table 15. The subjects 
were maintained on a diet of dog cubes (Epol, Johannesburg, 
South Africa). 
4.2.3 Purines Administered p~r os 
77 The procedure used here followed that of Sperling et al. • 
Oral administration of 0,5 g neomycin sulphate daily was 
initiated 3 days prior to the experiment and continued for the 
duration in order to minimise bacterial degradation of the fed 
purine. 0,5 g mandelamine was administered orally every 8 
hours for the duration of the experiment to prevent bacterial 
contamination of the urine. Anaesthesia was induced in Dl, 
D2 and Ml with thiopentone sodium and 10 F gauge Foley 
catheters were inserted into the bladders. The do gs we re 
fully recovered from anaesthesia before the purines were fed. 
In the ma le dog (M2), .urines were collected by the insertion 
each time of a 6 F gauge dog catheter up the urethra and into 
the bladder. The female dogs remained catheterised for the 
duration of H1e experiment. The male dogs' urine samples 
were collected in sterile bottles at 3, 6, 9, 18, 27, 42, 66, 
90 and 114 hours and stored at -20°C. After thawing, 0,5 ml 
of each well mixed sample was added to 1 ml distilled water in 
scintillation vials. 
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Table 15. The experimenta 1 animals used 1.n the 1.n vivo 
studies on administered purines. 
4.2.4 · Purines Administered Intravenously 
Dl and D2 had Foley catheters inserted as for the per os 
experiment. M3 and M4 had 6 F gouge dog cat he te rs in se rte d 
up the urethra and held in place with adhesive tape. All 
dogs had preplaced 16 and 18 gauge intravenous cannulas in 
the left and right cephalic veins respectively. An 
intravenous infusion of 5% dextrose solution was administered 
via the left cannula at 1 ml/min to ensure adequate urine flow. 
Urine fractions were aseptically collected for ten 15 min 
periods after injection of mixed labels. The volumes were 
noted and an aliquot transferred to sterile collection bottles 
0 and stored at -20 C. Blood samples were collected in 
heparinised syringes at approximately midway between the taking 
of each urine specimen. These were immediately centrifuged 
and the plasma stored in sterile collection bottles at -20°c. 
, The packed red blood cells of subject M4 were stored at -20°C 
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. as we 11. In Dl, D2 and M4, fi na l blood and urine sa mple s were 
collected a t ~l, 24 and 2 hours respectively. In M3, blood 
and urine were again collected at 19, 67 and 115 hours. The 
thawed urine samples were mixed well in prepara t ion for 
counting. The first 4 urines of each subject were diluted 
l in 10 with distilled water to ensure that the standard 
volume, 0,5 ml, used throughout for counting, di d not contain 
radioactivity levels above 100 000 cpm, since above this level, 
falsely low values can be obtained. 0 , 5 ml a 1 i quot s o f the 
diluted and undiluted urines were mixed with l ml distilled 
water in scintillation vials. In order to check whethe r 
suspended debris would affect the counts, 0,5 ml aliquots of 
centrifuged urines from D2 were identically prepared. The 
thawed plasma samples were well mixed and 0,5 ml of each 
transferred to Eppendorf tubes. Precipi t a t ion of the protein 
was accomplished by adding 0,1 ml 2,5 mol/l PCA. After 
centrifugation, the supernatant was neutralised wi th 25 .»-l 
5 mol/l K2co3 and centrifuged again. 0,5 ml of the supernatant 
was transferred to scintillation vials. To precipitate the 
protein in the red blood cells, 200 µl 2,5 mol/1 PCA was added - -
to 200JAl red blood cells. After centr i fugation, the supernatant 
was neutralised with 50 J--ll 5 mol/l K2co3 and centrifuged again. 
Of this, 200}-ll was transferred to scintillation vials. 
4.2.5 HPLC 
Samples were analysed isocraticly on a Waters solvent delivery 
system wi th the same anion exchange column as used in section 
3. 2. 12. The conditions were as follows: flow rate 3,2 ml/min, 
pressure 1800 psi, buffer 0,1 mol/l NH4H2Po4 pH 4,4, wavelength 
250 nm, and chart speed 75 cm/hr. 
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r 
· An absorpt ion spectrum analysis of allantoin showed tha t the 
absorption dropped off rapidly at wavelengths greater than 
245 nm. However at 250 nm, there was still sufficient 
absorption by allantoin and this was an appropriate compromise 
wavelengt h which separated the unlabelled markers, allantoin, 
hypoxanthine and uric acid (Fig. 10). Other unlabelled 
markers used were adenine, guanine, xanthine, adenosine, 
guanosine and inosine. These nucleosides and bases also 
absorbed sufficiently at 250 nm although these were not all 
separated by the conditions used. In an attempt to separate 
these, the pH of the 0,1 mol/_! NH4H2Po4 buffer was raised 
from 4,4 to 7,2 but this was unsuccessful. 
Precipitation of the proteins in the plasma and urine samples 
followed· the method used in Chapter 3. 
It was necessary to inject 250p.l deproteinised urine and 150,µ_! 
deproteinised plasma on to the column in the per os administered 
purines in order to reach a satisfactory level of counts. How-
ever, this was decreased to 100 }-ll for both when it was found 
that the elution times of uric acid varied greatly at the 
larger injection volume. Twenty second eluate fractions 
were collected and the 3H dpm and 14c dpm were plotted against 
ti me a s i n Fi g • l O • 
4.2.6 Selective Precipitation 
A method whereby uric acid was precipitated by the addition of 
saturated sodium urate was used to identify a peak found 
chromatographically. Addition of saturated sodium urate 
precipitates only labelled and unlabelled uric acid. The 
decrease in counts in the sample (which correspond to the 
4.8 
•counts in the precipitate) indicates the quantity of 
14c 
uric acid pres.ent (Table 19). 
A control ~rine was prepared by the addition of 20y._! 
5 µCi/ml 14c uric acid to 980 J.Al unlabelled dog urine. 
100 ~..!. of this was transferred to scintillation vials. 
The protein in 0,5 ml of the control urine and the urines 
to be counted was precipitated by the addition of 0,5 ml 
0 , 5 mo 1 / 1 HC l. After centrifugation, 50JL..!. of the supernatant 
was transferred to scintillation vials for counting. 
0,5 ml saturated sodium urate (made up by adding l mol/1 
NaOH to a · suspension of uric acid in water until the pH was 
roughly 7,5) was added to 0,5 ml of the deproteinised sample. 
This was put on ice for 30 minutes; then centrifuged, and the 
supernatant decanted. 100 J-ll of the supernatant was trans-
ferred to scintillation vials. The pellet was washed with 
0,5 ml saturated sodium urate and the wash supernatant 
transferred into scintillation vials for counting to ensure 
no appreciable losses occurred at this stage. The pellet 
was dissolved in 6 mmol/..!. NaOH warmed to 37°C, this being 
the molarity which should maximise the solubility of urate. 
50µ_!_ of this was transferred to scintillation vials. The 
rest was saved for HP LC. 
4.2.7 Output and Renal Clearance of Uric Acid 
Output and renal clearance of uric acid were measured on urines 
and sera after the intravenous administration of labelled 
purines. Six urines of measured volume (no. 4 to 9) from 
each subject were bulked. Aliquots from these and from the 
6th plasma sample of each subject were assayed for uric acid 
concentration by the uricase method described in section 2.1. 
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, 4 . 2.8 Scintillati on Coun tin g 
The suspens i on of the sample 1.n scintillation fluid and the 
counting was performed as in section 3.2.11. 
4.3 Re su 1 ts 
4.3.1 Purines Administered per os 
Evaluation of radioactivity in the urines must be considered 1.n 
the light of the fact that the urine volumes for this 
experiment were not measured. The urine may have been very 
diluted when collected giving artificially low values for the 
3 radioactivity. The H dpm in the four subjects' urine 
samples maintained a steady decline from 3 to 114 hours but did 
not reach background level by 114 hours. In contrast, the 
14c dpm rose rapidly to a maximum at approximately 6 hours, 
after which these levels dropped rapidly to background level 
by 18 hours. The actual counts obtained are not recorded 
hereasthey are only an approximate guide to the total quantity 
of radioactivity excreted in the urine speciments since the 
total urine volumes were not measured. The 14c/3H dpm ratios 
on the other hand provide more valid data because one label acts 
as a reference for the other. These 14c/3H dpm ratios 
(Fig. 8) were consistently lower in the Dalmatians; but 1.n all 
subjects, the ratios decreased progressively from 6 hours to 
reach very low values by 18 hours. From the 18 hour collection 
onwards, the ratios remained so low that they were excluded 
from the statistical evaluations (Table 16). The mean of the 
Dalmatian ratios at the 3, 6 and 9 hour collection points was 
three fold greater than the mean of the corresponding non-
























14c/3H dpm ratios from urines after per os 
administration of labelled purines 
(T-T:Dl; • --•:D2; o-o:Ml;v-v :M2). 
This is consistent with either a lower uptake of 14c uric acid 
relative to 3H hypoxanthine by the Dalmatian intestine compared 
with the non-Dalmatian or a higher excretion of 14c uric acid 
by the non-Dalmatian kidneys as compared to the Dalmatian. In 
order to differentiate between these two possibilities, the 
ratios were plotted in a different form (Fig. 9). The means of 
the four ratios at 3 and 9 hours were brought into line,or 
normalised, with the mean at 6 hours. The means at 3; 6 
and 9 hours were 22,5, 21,9 and 14,0 respectively. The values 
a~ 3 hours were multiplied by 0,97 (21,9 + 22,5) and the values 
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Table 16. 
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Statistical evaluation of the 
from urines of subjects after 
of labelled purines per os. 
Y(l) = non-Dalmatians. 
14C/3H . rat i os 
a dmi ni stra t ion 
X(l ) = Dalmatians, 
at 9 hours were multiplied by 1,57 (21,9 + 14,0) and listed in 
Table 17. This normal i sed t he means to 21,9 and the values 
are therefore directly comparable (Fig. 9). A more rapid 
. f 14c . . d b h D 1 · . ld excretion o ur ic aci y t e non- a ma ti ans wou cause 
a higher 14c/3H ratio than that in the Dalmatians at early time 
i ntervals after feeding. However, this trend would be reversed 
at later t ime intervals , and as seen in Fi gs. 9, t here 
is no tendency for the disparity between Dalmat i ans and non-
Dalmatians to alter with time. It can therefore be concluded 
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0 
1 2 3 
Urine no. 
Urinary 14c/3H ratios plotted so that the 
means are in line (T-T:Dl;•-•:D2; 
o-o : Ml ; v-v : M2 ) • 
3 hours 6 hours 9 hours 
32,4 41,0 41, l 
28,7 28,0 27, l 
20,5 11,0 12,5 
5,85 7,5 6,7 
Ratios 14c/3H dpms for the first 3 hours 
a f t e r nor ma l i s i n g the me a n s ( to 2 l , 9 ) • 
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14 . intestinal uptake o f C ura te b y t he Dalmatians . 
HPLC of t he un. nes at 3, 6, 9 a nd 27 hours showed pea k s for 
both 3H and 14c 1.n the regio~ of the allantoin marker . The 
profiles for Ml at 6 hours are plotted as an example in Fi g. 
10. A small peak opposite the hypoxanthine marker appeared 
3 1.n the H dpm plot of the 3 hour urine of a l l the dogs. This 
could be interpreted as some 3H hypoxanth i ne being excreted 
unaltered at early time intervals. Careful examina t ion of the 
3 14 H dpm and C dpm profiles in the region of the allantoin 
marker revealed two separate but overlapping peaks in the 
urines at 6, 9 and 27 hours as seen in Fig. 10. The 3H dpm 
peak eluted slightly earlier than the 
14c peak and very close to 
the void volume. It was also slightly wider than the 14c peak 
which s~ggested it consisted of two co mponents. Identifica t ion 
of the second component (assuming one was allantoin) was 
attempted by comparing the elution time with that ·of likely 
candidate compounds. The nucleosides adenosine, guanosine 
and inosine and the bases adenine,guanine and xanthine were 
chosen as possible candidates (see Fig. 1). However, saturated 
solutions of these compounds all eluted later than the peaks 
in question when injected under the same conditions. It was 
3 therefore concluded that the extra H component was not a 
nucleoside or a base. 
Altering the pH of the buffer (0,1 mol/l NH4H2
Po4 , pH 4,4) to 
pH 7,2 failed to separate the two components. 
As hypoxanthine was generally labelled, another possibility was 
3 that the extra H component was tritiated water. To determine 
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HPLC of urine from Ml at 6 hours. Fracti3ns 
of 20 ~econds duration were counted (O··O: .H dpm; 
•-e:14 c dpm; All, allantoin; Hx, Hypoxanthine; 
U.a., uric acid). The unlabelled markers were 
run separately. 
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injected, a nd the elua te under the peak wa s co l lected and 
counted. Evaporation in the presence of phosphor us pen to xi de 
under ' vacuum at 40~C reduced the total 3H dpm from 73 to 40 
while the 14c dpm remained similar (118 and 115). This 
confirms that 55 percent (40 x 100 + 73) of the triated label 
opposite the allantoin marker was tritiated water. 
4.3.2 Purines Administered Intravenously 
4 • 3 • 2 • l P la s ma 
The 3H dpm (Fig. 11) were unchanged in each subject for the 
first 2t hours of the experiment. Even in M3 where the last 
sample was collected at 115 hours, the 3H levels were still 
63% of those in the first · plasma sample. In comparison, the 
14c dpm dropped markedly over 2t hours and had reached background 
level by the 11th collection (which was at 20, 24, 19 and 21 
hours for Dl, D2, M3 and M4 respectively). 
The first plasma sample from D2 (Fig. llb) showed a progressive 
increase in both 14c and 3H dpm levels for the first hour after 
injection. In view of this it was considered necessary to 
ascertain whether the uptake of the labels into red blood cells 
a_ffected the plasma dpm. However, after counting an aliquot 
of deproteinised and centrifuged red blood cells from M3 at 
each collection period, it was found that the ratio 14c/3H 
dpm in the red blood cells remained similar for the 2t hour 
period. Furthermore, the actual dpm in the red blood cells 
over the 2t hour period remained essentially constant. _ This 
was taken to indicate that uptake into red blood cells did not 
cause the increase in 14c levels as seen in Fig. llb. The 
increasing counts in the plasma of D2 may be related to the 
56 
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Fig. 11. Dpms in plasma after intravenous administratio8 of 
labell~d purines (a=Dl, b=D.2, c=M3, d=M4,0••0: H dpm; 
•-•: 4c dpm). . 
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·metho d of administra t i on. It is pos sible t hat s o me periva scular 
leakage (due tq increased intravenous pressure while the label 
was injected) resulted in delayed absorption. 
The 14c dpm/3 H dpm ratios in the plasma fe 11 off rapidly and 
almost in parallel to each other (Fig. 12). The decline 1n the 
Dalmatian ratios are almost coincidential as are those in the non-
Dalmatians; however the Dalmatian ratios decrease more rapidly 
than the non-Dalmatians, and since plasma 3H levels remain 
essentially constant (Fig. 11), this represents a more rapid 
disappearance of 14c from the plasma in Dalmatians. 
To establish whether the Dalmatian and non-Dalmatian ratios 
were converging or diverging with time after injection of labels, 
the data was analysed further (Fig. 13). For each collection 
time, · the means of the Dalmatian ratios was divided by the means 
of the non-Dalmatian ratios. Because the same amount of labelled 
purines was injected each time resulting in identical ratios at 
- the start, the plot of these points can be considered to start 
(at time zero) at one. The points in Fig. 13 give an 
impression of bimodal curve which would indicate an initial rapid 
divergence followed by a levelling off between the Dalmatian and 
non-Dalmatian ratios in Fig. 12. A possible cause · (assuming 
hypoxanthine is handled similarly by all the dogs) of this 
divergence is increased renal excretion of the 14c label in the 
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Fig • . 1'3. 
4.3.2.2 Urine 
I I I 
0 1 2 
Time (hours) 
Further evaluation of the 14c/3H ratios 
fr~m plasmas after intravenous administra-
tion of labelled purines. Ratios of the 
non-Dalmatian means to the Dalmatian means. 
\ 
The cumulative counts in · the first ten urines were calculated 
and plotted as · percentages of the administered dose. Examples 
3 14 of the Hand C pe .rcentage cumulative plots are given in Fig. 
14 and 15 ·respectively. The values of the 3H label (Fig. 14) 
are compatible with a biomodal excretion. There is a rapid 
early phase and a slow late phase for the time period studied 
(2t hours). The half time (tt) was read from each curve as the 
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3H dpm cumulative in percent of administered 
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14 · · · C ·dpm cumulative in percent of administered 
dose for M3. The tt for this subject was 
66 minutes. 
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The variations in the tts in either label were so great that it 
was not possible to show a difference between Dalmatians and 
non-Do lmatians. However the tts of the 3H lobe 1 were different 
from those - of the 14c lobe 1 according to the student's t test 
at p less than 0,0001. This shows that the urinary excretion 
of the 3 H label (initially injected as 3H hypoxanthine) is 
different from the urinary excretion of the 14c label (initially 
· · t d 14c . . d) A 1th h d t t t t inJec e as uric aci • oug a concerte a emp o 
obtain all the urine was made, some losses might have occurred. 
The 14c/3H dpm ratios (Fig. 16) help to offset any incomplete 
urine collections which may disrupt the cumulative plot. The 
Dalmatian ratios are lower overall than the non-Dalmatians and 
fall to lower values still at an earlier stage. There appears 
to be a secondary rise at approximately 2 hours in the non-
Dalmatian ratios which are absent or less prominent in the 
Dalmatian ratios. However, since it has been shown that the 
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14c/3H dpm ratios from urines after intravenous 
administration of labelled pu.rines (T-T:Dl; 
•-•:D2; D···D :M3; "v• • •"v :M4J. 
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•predominantly as allantoin and Dalmati ans excrete these 
d . l . . d26 32 33 81 94 . t b . bl pre ominant y as uric aci , i may e possi e 
that this late rise signals a surge in excretion of 
14c 
allantoin by the non-Dalmatian. HPLC analysis of the excreted 
labelled component in the urine was therefore undertaken to 
investigate this possibility. 
4 • 3 • "2 • 3 HP LC 
Aliquots of the urine and plasma collections (corresponding to 
15 minute fractions of excreted urine and the plasma collected 
at the midpoint of each urine fraction) from each subject were 
injected onto the column. Fractions of 20 seconds duration 
of -the eluate from the column were collected. These 20 second 
fractions were counted and the level of radioactivity plotted. 
Fig. 17 shows as an example, HPLC of the first plasma collection 
from D1. The 3 H label elutes opposite the allantoin marker in 
a large, sharp peak. A second, s~aller peak appears opposite 
the hypoxanthine marker. The relative sizes of these two 
3 H peaks indicate a rapid conversion of hypoxanthine to 
allantoin and/or tritiated water. As the first peak elutes 
slightly earlier than the 14c peak opposite the allantoin 
marker, it would appear to be a combination of allantoin and 
water as assumed for the fed labels (section 4.3.1). 
14 
The C label elutes in two peaks - one opposite the allantoin 
marker and the other approximately opposite the uric acid 
marker. Examination of the degradation pathway of purines 
(Fig. 1) leads one to assume that the first peak must be 
14c allantoin. In later plasma collections, the 14c peak 




















































HPLC of the first. plasma collection from 
DL ~ractions of 20 seconds duration 
(O···O: H dpm; e-e: 14c dpm; All., 
allantoin; Hx. Hypoxanthine; ·u.a. 1 uric 
acid). The unlabelled markers were run 
separately. 
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14 . The second and larger C dpm peak elutes approximately 
o pp o s i t e t he u r i c a c i d ma r k e r i n Fi g • 17 • This must be 
the injected labelled uric acid still present in the plasma 
in this form. 
3 14 The 2 hour plasma HPLC analyses (not shown) gave Hand C 
profiles which were not greatly dissimilar to the 7t minute 
period (Fig. 17). These indicated that the levels of 
labels in both the injected hypoxanthine and the injected 
uric acid were declining in plasma parallel with the increase 
in labels opposite the allantoin marker. As shown in Fig. 
11, the overall levels of 
3
H remained virtually unchanged in 
the plasma over this period which emphasizes the value of 
HPLC analysis in defining the chemical constituents of the 
lobe lled · species. 
HPLC of the urines helped to confirm the plasma HPLC findings. 
Fig. 18 shows the results of the first (15 minute) collection 
from D2 as a typical example of the _Dalmatians and Fig. 19 
shows the results of the corresponding urine from M3. In 
both Dalmatian and non-Dalmatian, only a very minor 3H component 
eluted opposite the allantoin marker and most opposite the 
hypoxanthine marker. This there fore corresponds to injected 
3 H hypoxanthine which has been excreted rapidly via the kidneys. 
In the Dalmatians, the 14c label elutes almost entirely 1.n a 
peak between the hypoxanthine and uric acid markers. It was 
proposed that this later 14c peak was in fact uric acid. In 
contrast, in the non-Dalmatians, the 14c label was approximately 
equally distributed between a peak corresponding in position 
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HPLC of _ _.the first" ur_ine from D2. Fra·c1ions of 20 seconds duration (6,00 0:3H; e-e: 4c; 
All., allan t oin; tjx, h-rpoxanthine; U.a •. , uric ac-id). The unlabe led markers were run 
on a separ·ate HPLC anolysis. 
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Fig. 19. 
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HPLC of the first .urine from M3. Fr.act· ~ons 
of 20 seconds duration _(0···0:3H; e-·e: 4C; 
All., allontoin; Hx., hypoxan.thine; U.a·., 
uric acid). The unlabelled markers were run 
on a separate HPLC analy_sis. 
6..8 
.between the h ypoxant hine and ur ic acid mar kers . 
It was suspected that the 14c peak eluting between the hypox-
anthine and uric acid markers was in fact uric acid but that 
·it was eluting earlier than the marker, which had been injected 
in pure form on a separate HPLC analysis. This early elution 
could be brought about by the ionic effects of the rather large 
volume (250)-l_!) of neutralised PCA extract which was injected. 
To test this hypothesis the following method was devised. 
Selective precipitation of uric acid with unlabelled sodium 
urate was applied to the first and third urine collections 
from Dl (1.1 and 1.3 respectively). The calculated final 
dpm are listed in Tab le 19. The e ff e ct i ve ne s s of the method 
can be a s ce r ta i ne d from the recovery of the dpm in the control 
(an unlabelled urine to which 14c uric acid had been added). ., . 
Precipitation of the proteins did not effect the dpm in the 
control (sample l approximately = sample 2). Recovery in the 
control was 99% (sample 5 plus sample 8 plus sample 11 multiplied 
by 100 divided by sample 2). Similar recoveries were obtained 
from the labelled urines 3 14 both in the Hand C dpm. 
14 The percentage of C control recov~red in the pellet was 78. 
The percentages of urines 1.1 and 1.3 recovered in the pellets 
must therefore be multiplied by 0,78 to give the corrected 
percentages recovered. These are 90,5% for 1.1 and 74% for 
l.-3. 
To confirm the selectivity of the labelled uric acid pre_cipita-
tion, aliquots of the dissolved pellets of urines 1.1 and 1.3 
(samples 12 and 13 in Table 19) were analysed on HPLC, and in 
































































































































































































































































































































































































































·urate which was clearly identifi ed from its absorption profile 
(shown for urine 1.3 in Fig. 19). 
The percentages of 1.1 and 1.3 (90,5 and 74) recovered in the 
pellets indicate that nearly all the 14c label is in uric acid 
in the Dalmatian's first urine collection and slightly less 
30 minute s _ later . 
As a further method to confirm the identity of the predominant 
14c peaks on urine HPLC as uric acid and allantoin, 0,02 )-lCi of 
14c uric acid standard was treated with 10 U uricase for 10 
minutes to convert it to allantoin. This and untreated 14c 
uric acid was then added to aliquots of the first urine from 
M3 and analysed on HPLC. The radioactivity under 
the peaks of putative uric acid and allantoin was then 








Tab le 20. 
l 2 3 
Label led Label led . Lobel led 
urine urine with 14c urine with 
uric acid allantoin 
standard . standard 
the 4600 5500 8600 peak 
the 3800 7800 4500 peak 
HPLC of the first urine sample from M3 with . 14c 














5 10 15 
Fraction no. 
Fig. 19. HP LC a no l y sis o f the dis so l ve d 
' pellet of the third urine from 
Dl after selective precipitation 
of uri~ acid by saturated sodium 
urate ( o -. •o: 14c { -: un lobe lled 
marker profiles). · 
72 
· The majority of the extra dpm (approximately 5000) from 
the added uric acid and allantoin standards eluted in the anti-
cipated positions. 
As a consequence of these several confirmatory experiments, the 
identity of the two predominant 14c labelled species seen on 
HPLC could be confidently assigned to allantoin and uric acid. 
Table 21 compares the distribution of 14c radioactivity between 
uric acid and allantoin in the urine samples collected between 
0 and 15 minutes and between 1 hour 45 minutes and 2 hours after 







Percent in uric acid Percent in al la n toin 
0-0,25 hrs. 1,75-2 hrs. 0-0,25 hrs. 1,75-2 hrs. 
89 70 11 30 
85 75 15 25 
65 11 35 89 
60 7 40 93 
14c dpm in uric acid and allantion obtained by 
HPLC analysis or urines from two Dalmatians 
(Dl, D2) and two non-Dalmatians (M3, M4). 
Conversion of uric acid to allantoin clearly is much more rapid 
in the non-Dalmatians than in the Dalmations, with 90% of uric 
acid converted to allantoin by 2 hours after injection in the 
non-Dalmatian as compared with no more than 30% converted in the 
Dalmatian. 
4.3.2.4 Output and Renal Clearance of Uric Acid 
The bulked urine specimens represented a 90 minute collection 
73 
·period. The outp ut and renal clearance of uric acid was 
calculated by ~he following formulae: 
Output (mmol/hr) = quantity of urine (_!/hr) x urine cone. (mmol/!) 
Renal clearance of urate from the plasma (ml/min) 
= quantity of urine (ml/min) x urine cone. 
plasma cone. 
The results are given in Table 22. 
,Despite the fact that there is in this small sample no 
significant difference between Dalmatian and non-Dalmatian 
~lasma urate concentrations, there are very clear cut 
differences between both the output and renal clearance of 
uric acid in Dalmatians compared to non-Dalmatians when 
related to body weight. 
4.4 Conclusions 
The use of double-labelling of purines in in vivo experimental 
animal studies has a distinct advantage over the single labels 
used by researchers to date 12 18 19 42 64 65 74 75 The flux 
through one pathway can be compared to the flux through a 
re fere nee pathway. This is a useful way of offsetting the 
errors re lated to possible incomplete sample collections or 
inaccurate timing. These inaccuracies are more likely to 
o c cur i n e x p e r i me n ta l a n i ma l s t ha n ma n a s a n i ma 1 s o ft e n be co me 
excited and uncontrollable at the approach of an attendent. 
In the per os administration of double-labelled purines 
'\ 
(section 4.3.1), the ratios of uric acid to hypoxanthine 
collected in the urine were higher in the non-Dalmatian than 
the Dalmatian. Adjusting the ratios so that the means are 
















































































































































































































































































































· converge nt as would be the case if there was a decreased renal 
excretion by the non-Dalmatians. There is therefore a 
deficient intestinal absorption of uric acid relative to 
hypoxanthine in the Dalmatian as compared to the non-
-Dalmatian. 
In the intravenous administration of double-labelled purines 
(section 4.3.2) the dpm of hypoxanthine in urine as percent 
of administered dose (Fig. 14 & 15) and the dpm of hypox-
anthine in plasma (Fig. 11) show that this compound is not 
handled differently in the Dalmatian when compared to the 
non-Dalmatian. Hypoxanthine is therefore a useful reference 
comp o u n d for the st u d y o f u r i c a c i d me tab o 1 i s m i n t he ca n i n e • 
Tabulation of the dpm in confirmed uric acid and allantoin 
peaks on HPLC analysis of urines collected from Oto 15 minutes 
and 1 hour 45 minutes to 2 hours (Table 21) show that Dal-
matians excrete injected uric acid almost unchanged whereas 
non-Dalmatians excrete injected uric acid mainly as allantoin. 
The ratios of uric acid in the urine (referenced to hypoxanthine) 
show peaks of 14c label excretion at 2 hours in the non-Dalmatians 
which are absent or not prominent in the Dalmatians (Fig. 12). 
HPLC analysis of the 2 hourly urines show this to be mainly 
a llantoin (Table 21). The non-Dalmatians therefore convert 
uric acid to allantoin much more rapidly than the Dalmatians. 
This agrees with the hyperuricosuria and hypoallantoinuria 
reported in Dalmatians from other studies 26 33 94 That the 
Dalmatians (Dl and D2) used here were purebred for this anomaly 
is therefore confirmed. Further confirmation is apparent from 
Table 22 in section 4.3.2.4. The increased output of uric acid 


















, related to body weight. 
The increased tenal urate clearances (Table 22) confirm that 
there is a difference in the renal handling of urate between 
Dalmatians and non-Dalmatians as suspected by other 






. 5. GENERAL CONCLUSIONS 
The defect(s) in the uric acid metabolism of the Dalmatian 
coach hound has been the subject of sporadic research 
programs. Attempts have been made as discussed in Chapter 
1 to propose a single metabolic anomaly which would simply and 
concisely explain the defective uric acid uptake into red 
blood cells, uric acid conversion in the liver, and re-
absorption of uric acid from the renal tubules. The validity 
of two of these proposed defects have been questioned. The 
defective uric acid uptake by red blood cells as proposed by 
Harvey & Christensen 29 was not found by Duncan & Curtiss 24 . 
The defe~t in renal reabsorption 26 has been questioned by the 
data of Roch-Ramel & Peters69 since they found evidence in 
support of a difference in the secretion of uric acid in the 
straight portion of the proximal tubules. In Dalmatians, 
there is net secretion and in non-Dalmatians no net urate 
I 
. 68 
movement • The possibility of one anomaly of urate transport 
explaining both the liver and kidney defects has been questioned 
by Briggs and Sperling17 • Examination of the results of this 
thesis in the light of other researcher's data may help to 
clarify certain aspects of the difference in uric acid 
metabolism of Dalmatians from other breeds of dogs. 
Friedman & Beyers 26 showed that the total purine elimination 
(urinary uric acid nitrogen plus allantoin nitrogen) is no 
greater in Dalmatians than non-Dalmatians. There is, therefore, 
no over-production of purines. That there is increased urinary 
·output of uric acid in Dalmatians is wel1-established6 87 92 
7.8 
and has been conf i r med in these studies (sec ti on 4.3.2 . 4) . 
T d 1 · D l . 9 34 49 50 72 90 92 95 he increase urate c earance in a matians 
, has also been confirmed in section 4.3.2.4. This difference 
in renal clearance could result either from decreased tubular 
reabsorption of urate in the Dalmatian or i ncreased tubular 
secretion. The former would seem more likely and is supported 
by other studies 26 34 93 Increased clearance of urate acting 
on its own would tend to lower plasma urate concentrations. 
The fact that it does not, and that in the larger study 
summarised in section 2.3, Table 5, Dalmatian uric acid levels 
are shown to be significantly higher than non-Dalmatians is 
accounted for by the values for total output of uric acid 
especially when related to body weight. The urinary output of 
uric acid is greatly increased in the Dalmat i an and in Table 22, 
this -balance between increased output and increased clearance 
results in similar values for plasma urate concentrations. This 
also shows that two separate phenomena effect the urate levels 
and excretion in the Dalmatian, namely renal tubular reab-
sorption (or secretion), and urate production relative to 
al lantoi n. Although the total purine output (uric acid nitrogen 
plus allantoin nitrogen) is the same in Dalmatians and non-
Dalmatians26, the increased output of urate shown in Table 22 
is a consequence of the delay in conversion of circulating uric 
acid to allantoin shown in Table 21. 
The delayed uptak.e of uric acid by canine fibroblasts found in 
this study (secion 3.3) taKen in conjunction with the findings 
of Harvey & Christensen in red blood cells29 supports the 
concept of a generalised transport defect for uric acid. The 
deficient intestinal absorption of uric acid found here (section 
79 
4.3.1 ) together with the hi gh r e nal urate clearance i n the 
Dalmatian demonstrated in Table 21 also s upport a defective 
uric acid transport across cell membranes. The data from 
Jhis study is therefore in agreement with the concept of a 
generalised transport defect across cell me mbranes as first 
d b H & Ch . 29 Th . ff f propose y arvey ristensen • e primary e ect o 
this defect would be on the liver in cau si ng the i n c r eased 
plasma levels. Since the plasma uric ac i d levels found here 
(section 2.2.2) are higher than previously reported (Table 5) 
the defect in the kidney is of secondary importance. The in-
creased renal clearance of uric acid in the Dalmatian as 
compared to the non-Dalma t ian is not sufficient to maintain 
plasma uric acid concentrations in the Dalmatian as low as or 
lower than those in the non-Dalmatian. 
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ABBREVIATIONS 
PCA - perchloric acid 
UMP uridine-mono-phosphate 
UDPG - uridine-di-phosphate glucose 
UDP - uridine-di-phosphate 
UTP - uridine-tri-phosphate 
3H - tritiated or labelled with tritiated hydrogen 
14c - labelled with radioactive-14-carbon 
N.S. - not significant 
p - probabi 1i ty 
< - less than 
> - greater than 
All. - allantoin 
Hx. - hypoxanthine 
U.a. - uric acid 
STD. DEV. - standard deviation 
t - student's t test statistic 
DF - degree of freedom 
PROB - probability 
dpm - disintegratrions per minute 
cpm - counts per minute 
cone. - concentration 
·hr - hour 
min - minute 
log. - logarithm 
approx. - approximately 
nm - namome ter 
no. - number 
Fig. Figure 
HPLC - high pressure liquid chromatography 
Ci - C1:1rie 
N - normal 
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